Self-assembling, concentrated, lipid-based oxygen microparticles (LOMs) have been developed to administer oxygen gas when injected intravenously, preventing organ injury and death from systemic hypoxemia in animal models. Distinct from blood substitutes, LOMs are a one-way oxygen carrier designed to rescue patients who experience life-threatening hypoxemia, as caused by airway obstruction or severe lung injury. Here, we describe methods to manufacture large quantities of LOMs using an in-line, recycling, high-shear homogenizer, which can create up to 4 liters of microparticle emulsion in 10 minutes, with particles containing a median diameter of 0.93 microns and 60 volume% of gas phase. Using this process, we screen 30 combinations of commonly used excipients for their ability to form stable LOMs. LOMs composed of DSPC and cholesterol in a 1:1 molar ratio are stable for a 100 day observation period, and the number of particles exceeding 10 microns in diameter does not increase over time. When mixed with blood in vitro, LOMs fully oxygenate blood within 3.95 seconds of contact, and do not cause hemolysis or complement activation. LOMs can be manufactured in bulk by high shear homogenization, and appear to have a stability and size profile which merit further testing.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/adhm.201200350 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Characteristics of Early-Onset and Late-Onset Multiple Sclerosis in Patients from Lithuania.
Medicina (Kaunas)
January 2025
Department of Neurology, Faculty of Medicine, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Early-onset MS (EOMS) and late-onset MS (LOMS) differ in terms of symptom presentation, disease progression, and disability outcomes. This study aims to evaluate the clinical characteristics of patients with EOMS and LOMS in Lithuania. A retrospective analysis of patients' medical records was conducted at the Lithuanian University of Health Sciences, Kaunas Clinics Department of Neurology.
View Article and Find Full Text PDF[Not Available].
Recenti Prog Med
December 2024
Dipartimento di epidemiologia del Ssr del Lazio, Asl Roma 1.
Air pollution has no borders. Over 90% of the global population breathes air contaminated daily by pollutants such as fine particulate matter (PM 2.5 and PM 10), ozone, and nitrogen dioxide (NO2), with serious consequences for public health and the environment.
View Article and Find Full Text PDFPediatric, adult, and late-onset multiple sclerosis patients: A unified analysis of clinical profiles and treatment responses.
Mult Scler Relat Disord
January 2025
Sakarya University Faculty of Medicine, Department of Neurology, Sakarya, Turkey.
Objective: This study aimed to conduct a unified analysis comparing the clinical characteristics, disease progression, and treatment responses of pediatric-onset multiple sclerosis (POMS), adult-onset multiple sclerosis (AOMS), and late-onset multiple sclerosis (LOMS) patients.
Methods: Utilizing a retrospective cohort design, we analyzed the records of 269 patients from MS clinics and categorized them into the POMS (<18 years), AOMS (≥18 and <50 years), and LOMS (≥50 years) groups based on age at diagnosis. Data collection focused on demographics, clinical manifestations, disability scores, MRI findings, and treatment outcomes.
Incidence of late onset multiple sclerosis in Italy: a population-based study.
Sci Rep
November 2024
Department of Medical, Surgical Sciences and Advanced technologies G.F. Ingrassia, Section of Neurosciences, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy.
Article Synopsis
- Late onset multiple sclerosis (LOMS) accounts for 0.6 to 12% of all MS cases, but there's limited information on its incidence in the general population.
- A study in Catania, Italy, identified 183 LOMS patients (with a mean age of onset at 55.8 years), revealing an average annual incidence rate of 2.87 per 100,000 person-years.
- Over time, the incidence rate increased notably, particularly among individuals aged 60-69, suggesting that MS may begin at older ages.
The influence of menopause on multiple sclerosis.
Eur J Neurol
January 2025
Department of Neurology, Oslo University Hospital, Oslo, Norway.
Introduction: One third of the multiple sclerosis (MS) population consists of peri- or postmenopausal women. Many symptoms of menopause overlap those of MS. Some studies show increased speed of disability progression after menopause, while others indicate an unaltered trajectory.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!